Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Biomolecular Screening|April 28, 2011
Screening and identification of a novel class of TGF-β type 1 receptor kinase inhibitorQ Khai Huynh, Sarah J Wise, Keith A Koch, et al.Journal of Virology|June 3, 2024
Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaquesArchana Vidya Boopathy, Anurag Nekkalapudi, Janette Sung, et al.Plos One|June 22, 2012
The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase functionChristy M Hebner, Bin Han, Katherine M Brendza, et al.Mabs|September 25, 2025
Development of a PRAME pMHC targeted T cell engager for solid tumor therapyKatarzyna Skrzypczynska, Kristin Schimert, Heather Stephenson, et al.Hepatology (Baltimore, Md.)|April 5, 2020
Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis BStephane Daffis, Scott Balsitis, Jason Chamberlain, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)Dmitry O Koltun, Eric Q Parkhill, Rao Kalla, et al.Mabs|September 24, 2025
A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biologyShahzada Khan, Jeremy Lum, Heather Stephenson, et al.Cell Reports|July 27, 2025
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent diseaseChingwei V Lee, Hector Viadiu, Apurva Kalamkar, et al.Antimicrobial Agents and Chemotherapy|January 15, 2014
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrugJoy Y Feng, Guofeng Cheng, Jason Perry, et al.Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.Pageof 5